These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23033228

  • 1. Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.
    Dodds Ashley E, Drew R, Johnson M, Danna R, Dabrowski D, Walker V, Prasad M, Alexander B, Papadopoulos G, Perfect J.
    Pharmacotherapy; 2012 Oct; 32(10):890-901. PubMed ID: 23033228
    [Abstract] [Full Text] [Related]

  • 2. Hospital resource utilization and costs of inappropriate treatment of candidemia.
    Arnold HM, Micek ST, Shorr AF, Zilberberg MD, Labelle AJ, Kothari S, Kollef MH.
    Pharmacotherapy; 2010 Apr; 30(4):361-8. PubMed ID: 20334456
    [Abstract] [Full Text] [Related]

  • 3. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR, Herbrecht R, Mauskopf J, Schlamm HT, Marciniak A, Roberts CS.
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W, Wang Cheng J, Tong KB, Seifeldin R.
    Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
    Tong KB, Lau CJ, Murtagh K, Layton AJ, Seifeldin R.
    Int J Infect Dis; 2009 Jan; 13(1):24-36. PubMed ID: 18621562
    [Abstract] [Full Text] [Related]

  • 10. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y, Zimmerli S.
    Swiss Med Wkly; 2016 Jan; 146():w14281. PubMed ID: 26901377
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patients.
    Heng SC, Slavin MA, Chen SC, Heath CH, Nguyen Q, Billah B, Nation RL, Kong DC.
    J Antimicrob Chemother; 2012 Sep; 67(9):2274-82. PubMed ID: 22643193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.